Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Gatifloxacin; Ketorolac; Ketorolac Tromethamine; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Males or females > 50 years old

• Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.

• Likely to complete all study visits and able to provide informed consent

• Visual potential of 20/25 or better

Exclusion Criteria:

• · Prior use of topical ketorolac

• Known contraindications to any study medication or ingredients

• Active ocular diseases or uncontrolled systemic disease

• Active ocular allergies